Join Riccardo Stewart, Jeff Locke, Sam Acho, and Zach Miller on this episode of the AWM NFL Podcast as they break down the path to building multi-generational wealth for professional athletes. The team dives into the fundamentals of investing, using relatable football analogies to unpack the three essential “buckets” every athlete should consider—from safeguarding your financial foundation to accessing exclusive private market opportunities. Drawing from their own careers and insider expertise, they reveal strategies, lessons learned, and what every player needs to know to sustain a legacy far beyond the playing field. Don’t miss this game plan for smart investing and family prosperity.Connect with usCall or text: 602-989-5022Website: https://www.athletefamilyoffice.com/LinkedIn: https://www.linkedin.com/company/awmcapital/Instagram: https://www.instagram.com/awmcapital/Facebook: https://www.facebook.com/awmcapital/X: https://twitter.com/awmcapitalChapters(00:01) NFL Players and the Path to Investing(01:55) The First Bucket—Protective Reserve and Emergency Funds(03:42) Early Lessons and Communicating Financial Foundations(04:45) The Second Bucket—Public Market Investments(06:41) Understanding Public Versus Private Markets(09:02) The Third Bucket—Accessing Private Markets(11:13) Progression and Planning for Multi-Generational Wealth

In this episode of the Travel Buddy podcast, travel experts Ashley Martinez, Rachel Satow, and Ian Andersen unravel the real impact of loyalty programs on holiday travel decisions. Together, they share practical tips, surprising strategies, and personal stories about maximizing points, timing flights, and navigating peak travel stress. Whether you're debating between family gatherings or last-minute adventures, this conversation offers fresh insights into making every trip affordable—and even a little more fun. Tune in for expert advice, candid anecdotes, and clever ways to stretch your points further this holiday season.Chapters(00:01) Holiday Travel Decisions and Loyalty Programs(03:08) Maximizing Points and Flexible Itineraries(07:23) Rethinking Destinations and Travel Flexibility(10:12) Timing Strategies and Fare Class Tips(13:42) Ancillary Benefits and Earning Tactics(16:06) Navigating Peak Seasons and Status Perks(24:18) Strategic Use of Points, Cash, and Mixed Payments(33:23) Practical Tips and Rules of ThumbConnect with SwitchflyWebsite: https://www.switchfly.com/LinkedIn: https://www.linkedin.com/company/switchfly/X: https://twitter.com/switchflyYouTube: https://www.youtube.com/@SwitchflyOfficial

In episode 37 of "In the Interim…", Dr. Jeff Saver, Director of the UCLA Comprehensive Stroke and Vascular Neurology Program, details his shift from behavioral neurology to clinical stroke research after early engagement with multicenter trials like TOAST. The discussion covers the biology of acute ischemic stroke, quantifying neuronal loss, and the scientific underpinnings of “time is brain.” Dr. Saver outlines the evolution of endovascular therapy, from early device challenges to current reperfusion success rates exceeding 85%. Key methodological issues in stroke trial analyses are presented, including debate over endpoint selection—dichotomous versus ordinal approaches and the limitations therein. Special focus is placed on the utility-weighted modified Rankin Scale, which assigns empirically derived, patient-centered health values to each disability state, providing a comprehensive measure that captures both benefit and harm. The episode explores regulatory hesitancy, differing analytic preferences within the field, and the design prospects for neuroprotectant interventions. Heterogeneity in patient outcomes and implications for public health and trial methodology are addressed. The episode provides an empirical account of clinical trial endpoint selection, interpretation, and future directions in cerebrovascular research.Key HighlightsEarly career influences and pivotal trial participation.Pathophysiology and quantification of acute stroke injury.Endovascular device development and clinical impact.Comparative analysis of endpoint methods: dichotomous, ordinal, and utility-weighted approaches.Technical derivation and application of utility-weighted mRS.Ongoing regulatory and methodological debate.Heterogeneity in ischemic vulnerability and future trial directions.For more, visit us at https://www.berryconsultants.com/